According to data compiled by Johns Hopkins University, coronavirus has now killed more than 500,000 people worldwide, as the number of confirmed infections has exceeded 10 million.
According to Hopkins, the United States accounts for more than 20% of all reported deaths from Covid-19, more than in any other country in the world, followed by Brazil, Britain, Italy and France. However, comparing mortality between countries is difficult due to differences in reporting methods.
Earlier this month, the World Health Organization warned that the pandemic is accelerating globally, adding that the outbreak has entered a “new and dangerous phase.”
“It is clear that many people are tired of being at home. For obvious reasons, countries seek to open their societies and economies. But the virus is still spreading rapidly. He is still deadly, and most people are still at risk, ”said WHO Director-General Tedros Adhanom. Hebries said June 19th.
The death toll of Covid-19 exceeded 400,000 on June 8, according to data compiled by the World Health Organization, and exceeded 300,000 on May 16.
There are still no drugs approved by the US Food and Drug Administration for the treatment of Covid-19. However, the researchers found some success in accelerating recovery among patients with remdesivir Gilead. And earlier this month, researchers in the United States found that dexamethasone, a cheap and widely available steroid, reduces the risk of death by one third for patients with Covid-19 on mechanical ventilation and a fifth for those who receive additional oxygen.
According to WHO, there are currently 16 vaccine candidates in clinical trials. The potential AstraZeneca vaccine, which is being developed in collaboration with researchers from the University of Oxford, is currently under development, said WHO Principal Scientist Dr. Soumya Swaminathan at a virtual briefing on Friday. She added that the candidacy of the Art Nouveau American biotechnology company is not far behind.
WHO also called for $ 27.9 billion on Friday over the next 12 months, additional funding for ACT Accelerator, a public-private partnership that includes WHO research tools to combat Covid-19. According to WHO, funding will help accelerate the development of drugs and vaccines, preventing further infections, deaths and economic disruption.
According to Mike Ryan, executive director of the WHO emergency program, the virus is still spreading rapidly in many countries in the Americas.
“And therefore, the path to them, unfortunately, has not reached a peak for many countries in North and South America,” he said.